Popper, Soros and the Open Society
Karl Popper, known for his concept of falsifiability in the philosophy of science, also was a...
01:35:13
Podcasts de Open
A balanced omega-6/omega-3 ratio in the Greek Diet: the powerful aid in fighting obesity
The truths and myths about the relationship between omega-6 and omega-3 intake and prevention of...
22:15
Why we were wrong about dietary fat guidelines
Rahul Bahl, Open Heart associate editor, talks to Zoe Harcombe about her article: Evidence from...
15:48
CDIS 2014: Tackling global reimbursement considerations: How does this impact trial design?
By Perry Bridger. This is one of a series of podcasts of talks from the London Cardiovascular...
31:05
CDIS 2014: Commissioning through evaluation, and streamlining the commissioning process
By Wayne Bartlett-Syree and Mark de Belder. This is one of a series of podcasts of talks from...
28:00
CDIS 2014: Summit summary and closing comments
With John Martin. This is one of a series of podcasts of talks from the London Cardiovascular...
06:34
CDIS 2014: Inside NICE: Defining cost effectiveness and technology assessment
By Mirella Marlow. This is one of a series of podcasts of talks from the London Cardiovascular...
22:45
CDIS 2014: Funding opportunities from the British Heart Foundation
By Peter Weissberg, medical director, British Heart Foundation. This is one of a series of...
14:40
CDIS 2014: NIH initiatives - early stage funding opportunities for device innovation
By Jodi Black, deputy director, Office of Translational Alliances and Coordination, NIH. This is...
24:38
CDIS 2014: Innovation: Preclinical and imaging in device iteration discussion
This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation...
30:14
CDIS 2014: Preclinical evaluation case examples: How pathologists can streamline device development
By Michael Joner. This is one of a series of podcasts of talks from the London Cardiovascular...
17:46
CDIS 2014: Neurodeflection for TAVI: Establishing clinical need and approval pathway
By Pauliina Margolis, Keystone Heart. This is one of a series of podcasts of talks from the...
29:04
CDIS 2014: Intellectual property disasters I have lived through and you should avoid
By Maurice Buchbinder. This is one of a series of podcasts of talks from the London...
23:07
CDIS 2014: Implementing EMA guidelines for DES CE approval
With Bart Segers and Christine Shan. This is one of a series of podcasts of talks from the...
18:43
CDIS 2014: Can regulators facilitate innovation while balancing responsibilities for patient safety?
By Ian Hudson, chief executive Medicines and Healthcare Product Regulatory Agency. This is one...
33:10
CDIS 2014: British healthcare policy and funding for MedTech discussion
This is one of a series of podcasts of talks from the London Cardiovascular Device Innovation...
28:37
CDIS 2014: Targeted biologics: The future of medicine, innovation, and interventional therapeutics
By John Martin. This is one of a series of podcasts of talks from the London Cardiovascular...
22:20
CDIS 2014: Can the UK gain a competitive edge in BioTech? Role, goals, and challenges of NOCRI
By Mark Samuels, managing director, NIHR Office for Clinical Research Infrastructure. This is...
13:17
CDIS 2014: British health care policy in a global landscape
By Julian Huppert, Lib Dem MP for Cambridge. This is one of a series of podcasts of talks from...
11:01
CDIS 2014: The Yale-UCL Research and Device Evaluation Program: A trans atlantic academic initiative
By Alexandra Lansky. This is one of a series of podcasts of talks from the London Cardiovascular...
13:44
Premium
Plus